News | AseBio - Asociación Empresas Biotecnología

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine

Oryzon-Asebio-Biotecnologia

ORYZON reports financial results and corporate updates for half-year ending June 30, 2023

Susana de Antonio Head of Listing Spain de Euronext

#BIOSPAIN2023Interview | "We aim to facilitate the growth of European companies and help them become global leaders"

Susana de Antonio Horcajo, Head of Listing Spain at Euronext and Bronze Sponsor of BIOSPAIN 2023,…

Dámaso_Molero_CEO_3P_Biopharmaceuticals

#BIOSPAIN2023Interview | "We are witnessing scientific and technological advances that are revolutionizing the sector"

Dámaso Molero, CEO of 3P Biopharmaceuticals, Silver Sponsor of BIOSPAIN 2023, analyzes the snapshot…

Orikine

Orikine Bio closes €5.5m Series Seed Financing with Sabadell Asabys and AdBio

Financing · Corporate

New synthetic biology spin-off from the Centre for Genomic Regulation (CRG) in Barcelona developing…

Ignacio_Odriozola_LIM_Global

#BIOSPAIN2023 Interview | "Research continues to be underfunded and lacks sufficient resources"

BioSpain · Talento

In recent years, Spain has achieved significant progress that has improved its ability to attract…

Begoña-Torregorsa-AseBio-Aliado-Biotecnologia

#NewAllyAseBio | "AseBio have the same goal as us of protecting people and sustainability"

Healthcare · Corporate

Meet Globalfinanz, our new ally. We talked to Begoña Torregrosa, partner and head…

Biorreactores empleados en VIVEbiotech

VIVEbiotech participates in the European MAGIC project

Healthcare · Personalized medicine · Advanced therapies · Gene editing · International · EU projects · Financing

VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to…

Presidencia_España_Consejo_Europa

We analyze the role of biotechnology in the program of the Spanish Presidency of the EU

From AseBio, we have analyzed the program of the Spanish Presidency and where R&D and…

Primera conferencia Cátedra UAM PEACHES

The use of cell secretomes opens a new era of advanced therapies

Drug discovery · Innovative drugs · Personalized medicine · Advanced therapies

The UAM-PEACHES Chair on cell therapies has taken place at the Autonomous University of Madrid (UAM…